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Aphthous Ulcer Causes and Management 
 
Aphthous stomatitis , recurrent as a recurrent aphthous  
stomatitis (RAS) , is the most common painful oral mucosal 
disease
1
, characterized by the repeated formation 
of benign and non-contagious mouth ulcers (aphthae) in 
otherwise healthy individuals
2
, The term “aphthous” is derived 
from a Greek word “aphtha” which means ulceration .affecting 
approximately % 20 of population. Recurrent aphthous 
ulceration is a common problem in Jordanian adults
3
 
Recurrent aphthous ulcers poorly understood mucosal disorder. 
They occur in men and women of all ages, races and geographic 
regions, However, to date, no principal cause has been 
discovered. Since the aetiology is unknown, diagnosis is entirely 
based on history and clinical criteria and no laboratory 
procedures exist to confirm the diagnosis
4
 However, ulcers that 
resemble recurrent aphthous stomatitis in some aspects, such as 
their clinical appearance, can be found in systemic disorders 
such as Behçet's syndrome, gastrointestinal diseases such as 
gluten-sensitive enteropathy or inflammatory bowel disease, and 
immunodeficiency syndromes such as infection with the human 
immunodeficiency virus (HIV) or cyclic neutropenia. This 
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Clinical Types of aphthous ulcers6 
 Minor aphthous ulcers  :   
Are the most prevalent form and typically occurs in patients 
who are 5 to 19 years old. Outbreaks are characterized by a few, 
superficial, round ulcerations that are <10mm and accompanied 
by a gray pseudomembrane and erythematous halo. Minor 
aphthae are usually confined to the lips, tongue, and buccal 
mucosa 
 Major aphthous ulcers 
Have a wider distribution (commonly extending to the gingiva 
and pharyngeal mucosa), is larger in size, (>10mm), and has a 
longer duration of outbreak. Minor aphthae typically resolve 
within 14 days of presentation, whereas major aphthae may 
persist for over six weeks. Further, major aphthae pose a 
significant scarring risk as well 
 Herpetiform ulceration 
Presents with dozens of small, deep ulcers that often coalesce 
and therefore present as large ulcers with an irregular contour. 
Outbreaks are no scarring and typically resolve within one 
month. Regardless of the subtype, lesions can impair one’s 
ability to effectively speak, swallow, and maintain dental 
hygiene 
 Recurrent aphthous stomatitis 
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RAS, the most common ailment affecting the oral cavity, is 
characterized by recurrent disruption of the oral mucosa in the 
form of painful ulcers. It is a diagnosis of exclusion, and other 
causes of ulcerative stomatitis should be explored before a 
diagnosis of RAS is made.  
PATHOGENESIS OF RECURRENT APHTHOUS STOMATITIS7 
 
Several theories describing the etiopathogenesis of RAS, The 
pathogenesis of RAS is multifaceted with significant 
physiological interplay between the immune system, genetics, 
and environmental factors. Similar to other chronic 
inflammatory conditions, deoxyribonucleic acid (DNA) damage 
secondary to oxidative stress is thought to play a large role in 
recurrent ulcerations. In a recent case-control study, total 
oxidative status (TOS), total antioxidant status (TAS), and the 
TOS: TAS ratio (oxidative stress index, OSI) were used as 
parameters to assess oxidative damage in RAS patients against 
unaffected controls. The results strongly suggested that RAS 
patients have a systemic imbalance in the oxidant-to-antioxidant 
ratio favoring oxidative damage. The cause for this imbalance is 
likely multifactorial 
 
Evidence also suggests an immunological basis for the chronic 
inflammation in RAS patients. It is currently thought that an 
unknown antigen stimulates keratinocytes, resulting in cytokine 
secretion and leukocyte chemotaxis. TNF-α has been found to 
be significantly increased in the saliva of RAS patients. A recent 
study explored the significance of single nucleotide 
polymorphisms (SNP) in the genes for proinflammatory 
cytokines IL-1 and IL-6 in RAS. 
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Diagnosis 
A diagnosis of recurrent aphthous ulceration depends mainly on 
history and clinical examination, the microscopic picture of 
aphthous ulcer is non-specific the mucous membrane of 
aphthous ulcer shows superficial tissue necrosis with a fibrin 
purulent membrane covering the ulcerated area. The necrosis is 
covered by tissue debris and neutrophils. Epithelium is 
infiltrated by lymphocytes and few neutrophils. Intense 
inflammatory cell infiltration, predominantly neutrophils present 
immediately below the ulcer, mononuclear lymphocytes are 
seen in adjacent areas. Minor salivary glands commonly present 
in areas of aphthae exhibit focal periductal and perialveolar 
fibrosis and chronic inflammation. 8 
 
  
Predisposing factors
 
 
Although the specific cause of aphthous ulcers does not 
determined, many potential causes and risk factors can be 
presented: 
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 Genetics 
 
A genetic predisposition for the development of apthous ulcer 
is strongly suggested as about 40% of patients have a family 
history and these individuals develop ulcers earlier and are of 
more severe nature. Various associations with Human 
leukocyte antigen  have been reported. These associations 
vary with specific racial and ethnic origins.8 
 
 
 Trauma 
 
Trauma to the oral mucosa due to local anesthetic injections, 
sharp tooth, dental treatments, and toothbrush injury may 
predispose to the development of recurrent aphthous 
ulceration (RAU).  Wray et al.  in 1981 proposed that 
mechanical injury may aid in identifying and studying 
patients prone to aphthous stomatitis.8 
 
 Tobacco 
 
Several studies reveal negative association between cigarette 
smoking, smokeless tobacco and RAS. Possible explanations 
given include increased mucosal keratinization; which serves 
as a mechanical and protective barrier against trauma and 
microbes.  Nicotine is considered to be the protective factor 
as it stimulates the production of adrenal steroids by its action 
on the hypothalamic adrenal axis and reduces production of 
tumor necrosis factor alpha (TNF-α) and interleukins 1 and 6 
(IL-1 andIL-6).  Nicotine replacement therapy has been 
suggested as treatment for patients who develop RAU on 
cessation of smoking. 8 
 
 Drugs 
 
Certain drugs have been associated with development of 
RAU; these include angiotensin converting enzyme inhibitor 
captopril, gold salts, nicorandil, phenindione, phenobarbital, 
and sodium hypochloride. NSAIDS such as propionic acid, 
diclofenac, and piroxicam may also cause oral ulceration 
similar to RAS.8  
 
 
 Hematinic deficiency 
 
Deficiencies of iron, vitamin B12, and folic acid predispose 
development of RAS. Deficiencies of these hematinics are 
twice more common in these individuals than controls. 
Contrary findings in various studies relating the association 
of hematinic deficiency and RAS have been explained as due 
to varying genetic backgrounds and dietary habits of the 
study population.8  
 
 Hormonal changes 
 
Conflicting reports exist regarding association of hormonal 
changes in women and RAU. Studies state association of oral 
ulceration with onset of menstruation or in the luteal phase of 
the menstrual cycle. Mc Cartan et al , in 1992 established no 
association between apthous stomatitis and premenstrual 
period, pregnancy, or menopause.8 
 
 
 Stress 
 
Has been emphasized as a causative factor in RAU. It has 
been proposed that stress may induce trauma to oral soft 
tissues by parafunctional habits such as lip or cheek biting 
and this trauma may predispose to ulceration. A more recent 
study shows lack of direct correlation between levels of stress 
and severity of RAS episodes and suggests that psychological 
stress may act as a triggering or modifying factor rather than 
etiological factor in susceptible RAS patients.8 
 
 
 
 Microorganisms implicated in apthous ulcers 
 
Several microorganisms have been implicated in the 
pathogenesis of RAS. Several contrary findings have been 
reported in the various studies published. 
 
RAS and oral streptococci 
 
Oral streptococci have been considered as microbial agents in 
the pathogenesis of RAS. They have been implicated as 
microorganisms directly involved in the pathogenesis of these 
lesions or as agents which serve as antigenic stimuli, which in 
turn provoke antibody production that cross-react with oral 
mucosa. It has been suggested that L form of α-hemolytic 
streptococci, Streptococcus sanguis; later identified 
as Streptococcus mitis was the causative agent of this disease. 
Hoover et al. in 1986 demonstrated low levels of cross-
reactivity of oral Streptococci and oral mucosal antigens and 
considered the reactivity to be non-specific and clinically 
insignificant.8 
 
RAS and Helicobacter pylori 
 
H. pylori has been implicated as one of the organisms in the 
etiopathogenesis of RAS. H. pylori is a gram-negative that 
has been associated with gastritis and in chronically infected 
duodenal ulcers. H. pylori has been reported to be present in 
high density in dental plaque.  Porter et al. in 1997 measured 
the levels of IgG antibodies against H. pylori in patients with 
RAS and showed that no the frequency of anti- 
H. pylori seropositivity was not significantly elevated in 
patients with RAS and other ulcerative and non-ulcerative 
oral mucosal disorders.8 
 
 
Viruses as etiologic agents in RAS 
 
Various viruses have been implicated in the etiopathogenesis 
of recurrent apthous stomatitis. There have been several 
suggestive, but as yet there exists inconclusive evidence 
toward a viral etiology. Characteristics of aphthous ulcers 
which are indicative of infectious etiology include recurrent 
ulceration, lymphocytic infiltration, perivascular cuffing, 
presence of auto-antibodies, inclusion bodies in case of 
herpetiform ulcers and similarity of RAU to viral ulcerative 
diseases in animals.  Virtanen et al.  in 1995 demonstrated the 
presence of human cytomegalovirus DNA (HCMV) in 
biopsies of oral mucosal ulcers, but they were unable to rule 
out the presence of this virus which may have existed as a 
super infection or co infection from existing HCMV in saliva. 
Sun et al.  In 1996 demonstrated the presence of HCMV 
genomes by polymerase chain reaction in pre-ulcerative oral 
apthous tissues. They postulated that when viral infection 
occurs in oral epithelial cells an intense T-cell response is 
elicited against virus containing oral epithelial cells. They 
concluded that HCMV may play role in perpetuating local 
immune response in genetically predisposed individuals.8 
 
 Role of tumor necrosis factor alpha in RAS 
 
Tumor necrosis factor alpha (TNF-α) is a pro-inflammatory 
cytokine and is one of the most important cytokine implied in 
the development of new apthous ulcers in patients. The 
association of TNF-α in the development of RAS gains 
credence due to the fact that immunomodulatory drugs such 
as thalidomide and pentoxifylline have been found effective 
in the treatment of RAS. Thalidomide reduces activity of 
TNF-α by degrading its messenger RNA and pentoxifylline 
inhibits TNF-α production.8  
   
management8 
There is no definitive curative treatment for RAS. Possible 
systemic association with RAS must be ruled out, especially in 
cases where there is sudden development of ulceration in 
adulthood The treatment choices should be guided by the 
severity of the disease (the amount of pain), the frequency of 
ulceration, and the potential adverse effects of the medications, 
In the absence of a clearly defined cause, the treatment is aimed 
primarily at pain relief and the reduction of inflammation. 
effective treatment of the condition may result in the remission 
or amelioration of the ulcers 
 
Minor Ulcers 
For the management of minor aphthous ulcers, patients should 
avoid oral trauma (for example, from hard toothbrushes or foods 
such as toast) and acidic foods or drinks that may exacerbate 
pain or perhaps precipitate ulcers. Although nicotine-
replacement therapy may help people whose ulcers arise on 
smoking cessation, only a small open-label trial showed a 
benefit. Clinical experience suggests that topical analgesics 
(such as benzydamine or lidocaine) and protective bio adhesives 
(such as carmellose or cyanoacrylate) can help relieve 
pain; Topical corticosteroids may speed the healing of ulcers 
and reduce pain such as a 2.5-mg lozenge of hydrocortisone, 
taken four times daily for two weeks 
 
Antimicrobial mouthwashes may also benefit patients with 
recurrent aphthous stomatitis. Mouthwashes containing 
chlorhexidine gluconate or triclosan 
 
patients using a 0.2 percent chlorhexidine gluconate mouthwash 
three times daily for 6 weeks had significantly longer ulcer-free 
periods (mean, 22.9 days) than patients who received a placebo 
(mean, 17.5 days) 
 
 
Severe Aphthous Stomatitis 
For patients with severe recurrent aphthous stomatitis, possible 
therapies include systemic corticosteroids or thalidomide. A 
one-week course of 30 to 60 mg of oral prednisone or oral 
prednisolone (tapered over a second week) has been used in 
practice, although data that demonstrate a greater efficacy than 
with topical corticosteroids are lacking and there is an increased 
risk of adverse effects. In a randomized trial of patients with 
severe recurrent aphthous stomatitis, 45 percent of those treated 
with 100 mg of thalidomide daily for two months had fewer 
ulcers or none at all (but only while taking the medication), as 
compared with 3 percent of patients given placebo. Open-label 
studies suggest that thalidomide may also be effective at a lower 
dose (50 mg daily). Serious adverse effects including 
neuropathy and teratogenesis are possible, however, and 
thalidomide is not approved by the FDA for the treatment of 
aphthous ulcers, so it should be used cautiously and only in 
extreme cases.8 
 
Promised advanced methods for symptomatic treatment of RAS 
was presented as studies suggested that low-level laser therapy, 
like, Er, Cr: YSGG laser application at 0.25W without water 
may be appropriate to reduce pain and accelerate the healing
9
 
Vitamin B12 treatment may be beneficial to patients with mouth 
ulcers as an adjuvant therapy to relieve ulcer pain
10
 
 
Silver nitrate cautery appears to be an effective and rapid 
treatment option for pain relief in aphthous stomatitis. Also, this 
treatment shortens the healing time of ulcers
11
 
 
Daily omega-3 treatment achieved a significant reduction in 
number of ulcers, duration of ulcers, and level of pain by 3 
months that persisted for 6 months; a daily omega-3 regimen 
shows promise as therapy for treatment and management of 
patients with recurrent aphthous stomatitis
12
 
 
Conclusions 
There is still no conclusive etiopathogensis of RAS and 
consequently treatment modalities still handle symptoms rather 
than basic issues of prevention and curing . 
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